CONTACT US
EisnerAmper discuss the Q4 for 2017’s effect on venture capital and private equity, unicorn companies, valuations, IPOs and capital markets.

More Than 40 Unicorns Lead Best VC Year Since the Dot-Com Era

    

In this episode of a “Quarterly Wink & a Glance at Venture Capital,” EisnerAmper Director of Capital Markets Alan Wink gives us the highlights of Q4 and his thoughts on 2017 as a whole. Was it really the year of the unicorn? Finally, Alan looks ahead to the 2018 VC market.


Transcript

Dave Plaskow: Hello and welcome to EisnerAmper’s podcast series. We’re always interested in the latest trends and developments as well as any related business and accounting opportunities and challenges. Today we’re taking a look at the venture capital landscape for the fourth quarter of 2017. I’m your host Dave Plaskow and with us today is Allen Wink, a Director for EisnerAmper’s Capital Markets. Allen, welcome and thanks for being here.
Alan Wink: Thanks Dave.


More Podcasts in This Series
Venture Capital Breaks a Record in 2018

EisnerAmper Director of Capital Markets Alan Wink discusses venture capital and the record-setting year for VC investment. From unicorn companies, the brisk IPO activity, fundraising and exit values, Alan discusses if VC investment can keep up this furious pace in 2019.


Are We on Track for a $100 Billion in VC Investment for 2018?

EisnerAmper's Director of Capital Markets examines venture capital VC investment for the third quarter (Q3) of 2018. Companies continue to raise large pools of private capital and 2019 might be the year of the IPO and climbing stock prices with Uber and Airbnb.


A Look at the NJ Innovation Evergreen Fund

Governor Murphy’s Evergreen Fund in New Jersey will raise venture capital funding through tax credits. Companies in technology and life sciences can receive funding if the pass venture capital investor scrutiny and are located in New Jersey, providing little risk for investment.



About Alan Wink

Mr. Wink assists clients with capital budgeting, capital structuring and capital sourcing. He has worked with many tech and life science companies on developing the appropriate capital structure for their position in the business life cycle.

Contact Alan

* Required